Clinical Significance of Focal Breast Lesions Incidentally Identified by ![]() |
Cho, Young-Seok
(Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Choi, Joon-Young (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Lee, Su-Jin (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Hyun, Seung-Hyup (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Lee, Ji-Young (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Choi, Yong (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Choe, Yearn-Seong (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Lee, Kyung-Han (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kim, Byung-Tae (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) |
1 | Even-Sapir E, Lerman H, Gutman M, Lievshitz G, Zuriel L, Pollizk A, et al. The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT. Eur J Nucl Med Mol Imaging 2006;33:541-52 DOI |
2 | Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ, Park K, et al. Focal thyroid lesions incidentally identified by integrated F-18 FDG PET/CT: clinical significance and improved characterization. J Nucl Med 2006;47:609-15 |
3 | Bakheet S, Powe J, Ezzat A, Bakri Y. Incidental secondary primary in the breast detected by F-18 FDG positron emission tomography scan. Clin Nucl Med 1998;23:616 DOI ScienceOn |
4 | Minamimoto R, Senda M, Uno K, Jinnouchi S, Iinuma T, Ito K, et al. Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey. Ann Nucl Med 2007;21:481-98 DOI ScienceOn |
5 | Korn RL, Yost AM, May CC, Kovalsky ER, Orth KM, Layton TA, et al. Unexpected focal hypermetabolic activity in the breast: significance in patients undergoing F-18 FDG PET/CT. Am J Roentgenol 2006;187:81-5 DOI ScienceOn |
6 | Miyake K, Hayakawa K, Nishino M, Nakamura Y, Morimoto T, Urata Y, et al. Benign or malignant? Differentiating breast lesions with computed tomography attenuation values on dynamic computed tomography mammography. J Comput Assist Tomogr 2005;29:772-9 DOI ScienceOn |
7 | Nguyen BD. Incidental PET/CT detection of thyroid and breast cancer durinig recurrence of colorectal carcinoma. Clin Nucl Med 2007;32:59-63 DOI ScienceOn |
8 | Avril N, Rosé CA, Schelling M, Dose J, Kuhn W, Bense S, et al. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol 2000;18: 3495-502 DOI |
9 | Gutman F, Alberini JL,Wartski M, Vilain D, Stanc EL, Sarandi F, et al. Incidental colonic focal lesions detected by FDG PET/CT. Am J Roentgenol 2005;185:495-500 DOI ScienceOn |
10 | Are C, Hsu JF, Schoder H, Shah JP, Larson SM, Shha AR. FDG-PET detected thyroid incidentalomas: need for further investigation? Ann surg oncol 2006;14:239-47 DOI ScienceOn |
11 | Schoder H, Conen M. Screeing for cancer with PET and PET/CT: potential and limitations. J Nucl Med 2007;48:4S-18S |
12 | Choi JY, Lee KS, Kwon OJ, Shim YM, Baek CH, Park K, et al. Improved detection of secondary primary cancer using integrated F-18 fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging J Clin Oncol 2005; 23:7654-59 DOI ScienceOn |
13 | Ishimori T, Pantel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 2005;46:752-57 |
14 | Dockery KF, Puri S, Qazi R, Davis D. FDG-PET on the trail of an unsuspected primary malignancy in the breast. Clin Nucl Med 2008;33:175-80 DOI ScienceOn |
15 | Kim SK, Kang KW, Roh JW, Sim JS, Lee ES, Park SY. Incidental ovarian F-18 FDG accumulation on PET: correlation with the menstrual cycle. Eur J Nucl Med Mol Imaging 2005;32: 757-63 DOI |
![]() |